InveniAI
InveniAI is a global leader in applying AI and Machine Learning to identify and accelerate transformative therapies for diseases with unmet medical needs. Their proprietary technology platform, AlphaMeld®, integrates complex scientific, medical, chemical, and biological data to enable experts to quickly search for treatment options at unprecedented speed and scale. This platform facilitates rapid prioritization of biological targets and modalities, maximizing safety and efficacy. InveniAI has a decade of experience and has engaged in over 150 biopharma industry collaborations. The company also has a sister company, BioXcel Therapeutics, focused on neuroscience and immuno-oncology programs. InveniAI boasts a diverse global team of domain experts and is committed to creating a lively and diverse work environment.
InveniAI
InveniAI is a global leader in applying AI and Machine Learning to identify and accelerate transformative therapies for diseases with unmet medical needs. Their proprietary technology platform, AlphaMeld®, integrates complex scientific, medical, chemical, and biological data to enable experts to quickly search for treatment options at unprecedented speed and scale. This platform facilitates rapid prioritization of biological targets and modalities, maximizing safety and efficacy. InveniAI has a decade of experience and has engaged in over 150 biopharma industry collaborations. The company also has a sister company, BioXcel Therapeutics, focused on neuroscience and immuno-oncology programs. InveniAI boasts a diverse global team of domain experts and is committed to creating a lively and diverse work environment.